Pregled bibliografske jedinice broj: 464545
Clinical Implication of Activin A, Inhibin A, and Their Receptors mRNA Expression in Thyroid Papillary and Follicular Carcinomas
Clinical Implication of Activin A, Inhibin A, and Their Receptors mRNA Expression in Thyroid Papillary and Follicular Carcinomas // 22th Annual Congress of the European Association of Nuclear Medicine – EANM’09
Barcelona, Španjolska, 2009. (poster, nije recenziran, sažetak, znanstveni)
CROSBI ID: 464545 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Clinical Implication of Activin A, Inhibin A, and Their Receptors mRNA Expression in Thyroid Papillary and Follicular Carcinomas
Autori
Glavas-Obrovac, Ljubica, ; Vladika, Ivan, ; Stefanic, Mario ; Suver, Mirjana ; Mihaljevic, Ivan
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Skup
22th Annual Congress of the European Association of Nuclear Medicine – EANM’09
Mjesto i datum
Barcelona, Španjolska, 10.10.2009. - 14.10.2009
Vrsta sudjelovanja
Poster
Vrsta recenzije
Nije recenziran
Ključne riječi
Activin A ; Inhibin A ; Thyroid Papillary and Follicular Carcinomas
Sažetak
Aim: To determine clinical implications of activin A (ActA), inhibin A (InhA), and their receptors ActRI and ActRIIB mRNA expression profile testing in papillary (PTC) and follicular (FTC) thyroid carcinoma. Methods: Tissue samples were divided in 6 groups: 27 PTC, 21 FTC, 11 Hürthle cell carcinomas (HC), 16 follicular adenomas (FA), 15 Hürthle cell adenomas (HA) and 26 euthyroid multinodular goiters (MNG). RNA was isolated from 10-μm paraffin tissue sections. Gene expression was studied using reverse transcription-polymerase chain reaction (RT-PCR). An internal control gene was HPRT1. ImageQuantTL program was used for relative quantification of RT-PCR bands. Data, expressed as medians (interquartile ranges), were processed using Kruskall-Wallis test with Schaich- Hamerle post-hoc analysis. Results: InhA, ActA and ActRI, but not ActRIIB mRNA, were expressed in the majority of tissue samples. InhA mRNA was over- expressed in HA relative to FA (P=0.00044), FTC (P=10-3) and PTC (P=2.9x10-5). HC were indistinguishable from HA, as well as FTC from FA. In contrast, InhA mRNA was consistently overexpressed in Hürthle cell neoplasms when compared to follicular variants [181 (142-205) vs. 89 (70-112), HA vs. FA, P=5.5x10-5 and 164 (115- 176) vs. 98 (81-107), % HPRT1 mRNA, HC vs. FTC, P=7.9x10-5]. Moreover, InhA mRNA was over- expressed in metastatic PTC (n=10) relative to non-metastatic forms [99 (92-117) vs. 84 (76-88), % HPRT1 mRNA, pN0 vs pN1+, P=0.007] ; no other differences were observed between PTC, FTC and MNG. Additionally, ActRI mRNA expression was down- regulated in FA, FTC and PTC relative to MNG (P=1.8x10-5, 6.8x10-4 and 3.3x10-4), whereas ActA mRNA was under-expressed in PTC relative to FA and, marginally, HC (P=2.3x10-3and 8.6x10-3). Neither pT stage, nor age were related to mRNA expression in cancerous tissue specimens. Conclusion: Activin system is involved in the maintenance of homeostasis in normal and transformed thyrocytes: InhA, ActA and the activin signaling pathway are differentially affected by cell transformation over a broad spectrum of neoplastic phenotypes and may play role in thyroid tumorigenesis. Here, we implicate InhA mRNA expression as a possible marker of PTC aggressiveness, metastatic potential and progression.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
219-2192190-2182 - Osobitosti koštane pregradnje u bolesnika s urolitijazom (Milas-Ahić, Jasminka, MZOS ) ( CroRIS)
Ustanove:
Klinički bolnički centar Osijek,
Akademija medicinskih znanosti,
Medicinski fakultet, Osijek,
Sveučilište J. J. Strossmayera u Osijeku
Profili:
Mirjana Suver Stević
(autor)
Ivan Mihaljević
(autor)
Mario Štefanić
(autor)
Ivan Vladika
(autor)
Ljubica Glavaš Obrovac
(autor)